The first drug to treat a lack of female sexual desire has been approved by federal authorities.
The drug flibanserin, which has been coined ‘female Viagra,’ is intended to treat women with a condition called hypoactive sexual desire disorder (HSDD) that’s characterized by lagging libido. On Tuesday, the drug was approved by the U.S. Food and Drug Administration. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.
Although the drug is being called a “Viagra” for women, it actually works quite differently. You can see how below.
Read next: What 8 Medical Experts Think About ‘Female Viagra’
Download TIME’s mobile app for iOS to have your world explained wherever you go
- Who Will Be TIME's Person of the Year 2023?
- Why Cell Phone Reception Is Getting Worse
- The Dirty Secrets of Alternative Plastics
- Column: It's Time to Scrap the Abraham Accords
- Israeli Family Celebrates Release of Hostage Grandmother
- In a New Movie, Beyoncé Finds Freedom
- The Top 100 Photos of 2023
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
